Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Aptevo Therapeutics Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 29 | 10 | −19 |
| Shares | 1.93M | 2.64K | −1.93M (−99.9%) |
| Value | $349.7K | $12.4K | −$337.3K (−96.5%) |
New holders (1)
Institutions that held Aptevo Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 100 | $469 | 0.00% |
Sold out (20)
Institutions that held Aptevo Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 516,789 | $94.0K |
| Sabby Management, LLC | 349,471 | $63.3K |
| Citadel Advisors LLC | 262,124 | $47.4K |
| Schonfeld Strategic Advisors LLC | 159,000 | $28.8K |
| Squarepoint Ops LLC | 138,697 | $25.1K |
| Millennium Management LLC | 104,608 | $18.9K |
| Vanguard Group Inc | 91,725 | $16.6K |
| Armistice Capital, LLC | 61,130 | $11.1K |
| Cantor Fitzgerald, L. P. | 58,532 | $10.6K |
| Geode Capital Management, LLC | 43,201 | $7.82K |
| Northern Trust Corp | 14,121 | $2.56K |
| Two Sigma Securities, LLC | 11,248 | $2.04K |
| Baader Bank INC | 15,086 | $2.03K |
| Franklin Resources Inc | 10,997 | $1.99K |
| State Street Corp | 10,941 | $1.98K |
| Divergent Wealth Advisors, LLC | 10,000 | $1.81K |
| Allworth Financial LP | 17 | $4 |
| Citigroup Inc | 10 | $2 |
| Bank of America Corp | 6 | $1 |
| UBS Group AG | 5 | $1 |